AstraZeneca plc (LON:AZN) had its Overweight rating reiterated by Barclays with a GBX 8,200 price target

Analyst Ratings For

AstraZeneca plc (LON:AZN)

Story continues below

Today, Barclays reiterated its Overweight rating on

AstraZeneca plc (LON:AZN) with a price target of GBX 8,200.

There are 9 Buy Ratings, 6 Hold Ratings, 3 Sell Ratings, no Strong Buy Ratings on the stock.

The current consensus rating on

AstraZeneca plc (LON:AZN) is Hold with a consensus target price of GBX 7,062.50 per share, a potential .

Some recent analyst ratings include

  • 10/9/2019-
    AstraZeneca plc (LON:AZN) had its Overweight rating reiterated by Barclays with a GBX 8,200 price target
  • 10/8/2019-
    AstraZeneca plc (LON:AZN) had its Buy rating reiterated by Bank of America with a GBX 8,500 price target
  • 10/1/2019-
    AstraZeneca plc (LON:AZN) had its Reduce rating reiterated by HSBC with a GBX 5,180 price target
  • 9/30/2019-
    AstraZeneca plc (LON:AZN) had its Buy rating reiterated by Shore Capital

    Recent Trading Activity for

    AstraZeneca plc (LON:AZN)
    Shares of

    AstraZeneca plc closed the previous trading session at 7,062.00 up +53.00 0.76% with 43.43 shares trading hands.

    An ad to help with our costs